FOR HEALTHCARE PROVIDERS

Evidence-Based Repurposing for Your Patients

Off-Label Prescribing Resources

Our AI identifies FDA-approved medications with strong evidence for new indications. While off-label prescribing is legal and often necessary, we provide the evidence base you need to make informed decisions.

Recent Findings

For Treatment-Resistant Depression:

  • Existing medications with rapid-onset potential

  • Safety profiles in combination with SSRIs

  • Dosing recommendations from published studies

For Chronic Pain:

  • Non-opioid alternatives with CNS activity

  • Multimodal approaches using available drugs

  • Patient selection criteria

Educational Resources

  • Monthly webinars on repurposing opportunities

  • CME-eligible programs (in development)

  • Quick-reference prescribing guides

  • Patient education materials

Request Custom Analysis

Have a challenging case? Our AI can analyze options for specific patient profiles. Submit Query

Note: Our analyses are for educational purposes. Clinical decisions remain the responsibility of treating physicians.